Homoepibatidine
Latest Information Update: 21 May 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Analgesics; Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 02 Sep 1998 No-Development-Reported for Pain in China (Unknown route)
- 26 Sep 1996 New profile